By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Horizon Discovery today announced a collaboration with Promega to develop next-generation predictive human disease models.

The partnership, it said, centers on delivering "endogenous gene reporting capabilities in the form of Promega's luciferase and HaloTag reporter technologies" combined with Horizon Discovery's homologous recombination-based precision genome editing technology called rAAV Genesis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.